opportunities and challenges in early breast cancer: do parp inhibitors have a role?
Published 3 months ago • 8 plays • Length 27:25Download video MP4
Download video MP3
Similar videos
-
1:13:00
expanding the benefits of parp inhibitors to more patients with breast cancer and earlier settings
-
4:59
future role of parp inhibition in brca breast cancer
-
51:57
the role of parp in early stage breast cancer
-
3:31
distinguishing between parp inhibitors in breast cancer
-
2:15
parp inhibitors in metastatic breast cancer: where are we now?
-
16:27
clinical updates in hereditary breast cancer: highlights from vienna 2023
-
2:21
olaparib: predicting response in breast cancer
-
18:32
usmle ace video 261: breast pathologies - common benign disorders and malignant tumors
-
48:28
parp inhibitors for the treatment & prevention of hereditary breast & ovarian cancer
-
47:27
parp inhibitors: a breakthrough in cancer therapy?
-
2:47
talave: induction talazoparib with parp inhibition in breast cancer
-
9:21
dr. litton on activity of talazoparib in advanced brca1/2 breast cancer
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer
-
3:17
the future of parp inhibitors in metastatic breast cancer
-
13:20
parp inhibitors for early, brca-mutant breast cancer - medpage today
-
3:58
brca breast cancer: the advent of parp inhibitors
-
1:12
dr. joanne blum on the function of talazoparib in locally advanced and/or metastatic breast cancer
-
7:13
final insight: parps and gbrca in breast cancer
-
24:56
gynecologic cancer education: parp inhibitor therapy